Wanbangde Pharmaceutical Holding Group Co., Ltd.
002082.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | CN¥4 | CN¥4 | CN¥5 | CN¥9 |
| - Cash | CN¥0 | CN¥0 | CN¥0 | CN¥1 |
| + Debt | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| Enterprise Value | CN¥5 | CN¥5 | CN¥6 | CN¥9 |
| Revenue | CN¥1 | CN¥2 | CN¥2 | CN¥2 |
| % Growth | -6.4% | -13.7% | -7.5% | – |
| Gross Profit | CN¥1 | CN¥1 | CN¥1 | CN¥1 |
| % Margin | 41.3% | 40.5% | 52.3% | 48.2% |
| EBITDA | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 11.8% | 10.6% | 18.9% | 15.8% |
| Net Income | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| % Margin | 3.8% | 3.2% | 5.2% | 8.6% |
| EPS Diluted | 0.091 | 0.08 | 0.152 | 0.27 |
| % Growth | 13.7% | -47.4% | -43.7% | – |
| Operating Cash Flow | CN¥0 | -CN¥0 | -CN¥0 | CN¥0 |
| Capital Expenditures | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |
| Free Cash Flow | CN¥0 | -CN¥0 | -CN¥0 | -CN¥0 |